General IV Therapy Information Wikipedia
For type 2 diabetes, NICE guidance (NG28) recommends their use as second- or third-line therapy when metformin alone provides inadequate control, particularly in patients who would benefit from weight loss or where hypoglycaemia risk must be minimised
Some clinics and wellness practices offer compounded formulations of semaglutide with vitamin B12
Biochem Biophys Res Commun 291:13021308 Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE, Sitagliptin 036 Study Group (2007) Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes
Acknowledgements The authors thank the Vellore Institute of Technology-Vellore for providing support and facilities